Sarah Sanghavi
@sarahsanghavi.bsky.social
Intensivist, Nephrologist @uwnephrology.bsky.social | Via UT Austin, UTSW, WashU, and Mt. Sinai | Views mine
https://nephrology.uw.edu/people/faculty/sanghavi-s
#nephsky #medsky
https://nephrology.uw.edu/people/faculty/sanghavi-s
#nephsky #medsky
I should mention that this study came out after that presentation, but I still think changes in blood flow rate are likely inconsequential for clotting. academic.oup.com/ckj/advance-...
Higher blood flow rates in anticoagulation free CRRT improve circuit survival and clinical outcomes
AbstractObjective. Anticoagulation-free continuous renal replacement therapy (CRRT) is an essential modality for managing patients with a high bleeding ris
academic.oup.com
December 5, 2025 at 2:36 AM
I should mention that this study came out after that presentation, but I still think changes in blood flow rate are likely inconsequential for clotting. academic.oup.com/ckj/advance-...
Reposted by Sarah Sanghavi
All ELISAs that use biotin strepavidin at risk for this. Which are pretty much all ELISAs
December 2, 2025 at 12:24 AM
All ELISAs that use biotin strepavidin at risk for this. Which are pretty much all ELISAs
Agree, much prefer the bit of inotropy and precapillary pulmonary vasoconstriction from NE.
journals.lww.com/cjasn/fullte...
journals.lww.com/cjasn/fullte...
journals.lww.com
November 23, 2025 at 2:26 AM
Agree, much prefer the bit of inotropy and precapillary pulmonary vasoconstriction from NE.
journals.lww.com/cjasn/fullte...
journals.lww.com/cjasn/fullte...
Very odd. The rationale doesn’t reference any sources about titration rate either.
November 22, 2025 at 9:24 PM
Very odd. The rationale doesn’t reference any sources about titration rate either.
And beautiful slides as always.
November 9, 2025 at 3:07 AM
And beautiful slides as always.